Capital Advisory Group Advisory Services, LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 171 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2019. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital Advisory Group Advisory Services, LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2021$14,0000.0%1500.0%0.01%0.0%
Q2 2021$14,000
-17.6%
1500.0%0.01%
-28.6%
Q1 2021$17,000
-19.0%
1500.0%0.01%
-22.2%
Q4 2020$21,000
-16.0%
150
-50.0%
0.01%
-30.8%
Q3 2020$25,000
+8.7%
3000.0%0.01%0.0%
Q2 2020$23,000
+76.9%
3000.0%0.01%
-18.8%
Q1 2020$13,0000.0%3000.0%0.02%
+77.8%
Q3 2019$13,000
-31.6%
3000.0%0.01%
-30.8%
Q2 2019$19,000
-9.5%
3000.0%0.01%
-13.3%
Q1 2019$21,0003000.02%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q2 2019
NameSharesValueWeighting ↓
Iguana Healthcare Management, LLC 75,000$4,658,0002.63%
COLUMBIA WANGER ASSET MANAGEMENT LLC 1,364,434$84,745,0001.21%
CAPITAL INTERNATIONAL LTD /CA/ 259,700$16,130,0001.07%
Aureus Asset Management, LLC 65,670$4,079,0000.69%
Capital International Sarl 124,320$7,722,0000.67%
CAPITAL GUARDIAN TRUST CO 512,430$31,827,0000.58%
ROCKEFELLER FINANCIAL SERVICES INC 408,379$25,365,0000.50%
Rock Springs Capital Management LP 160,500$9,969,0000.50%
Hood River Capital Management LLC 112,296$6,975,0000.48%
Capital International, Inc./CA/ 52,700$3,273,0000.47%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders